Arsalan Yousuf

Arsalan Yousuf

Auto-generated profile, based on publicly available information

Arsalan Yousuf

Molecular Horizons, Faculty of Science, Medicine and Health University of Wollongong Wollongong New South Wales Australia

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2018 in Science Signaling
Verified
Journal Article
Closed access
PDF file
EMElke Miess
Elke Miess
AGArisbel B. Gondin
Arisbel B. Gondin
AYArsalan Yousuf
Arsalan Yousuf
RSRalph Steinborn
Ralph Steinborn
NMNadja Mösslein
Nadja Mösslein
MCMeritxell Canals
Meritxell Canals
G protein receptor kinases (GRKs) and β-arrestins are key regulators of μ-opioid receptor (MOR) signaling and trafficking. We have previously shown that high-efficacy opioids such as DAMGO stimulate a GRK2/3-mediated multisite phosphorylation of conserved C-terminal tail serine and threonine residues, which facilitates internalization of the receptor. In contrast, morphine-induced phosphorylation of MOR is limited to Ser375 and is not sufficient to drive substantial receptor internalization. We report how specific multisite phosphorylation controlled the dynamics of GRK and β-arrestin interactions with MOR and show how such phosphorylation mediated receptor desensitization. We showed that GRK2/3 was recruited more quickly than was β-arrestin to a DAMGO-activated MOR. β-Arrestin recruitment required GRK2 activity and MOR phosphorylation, but GRK recruitment also depended on the phosphorylation sites in the C-terminal tail, specifically four serine and threonine residues within the 370TREHPSTANT379 motif. Our results also suggested that other residues outside this motif participated in the initial and transient recruitment of GRK and β-arrestins. We identified two components of high-efficacy agonist desensitization of MOR: a sustained component, which required GRK2-mediated phosphorylation and a potential soluble factor, and a rapid component, which was likely mediated by GRK2 but independent of receptor phosphorylation. Elucidating these complex receptor-effector interactions represents an important step toward a mechanistic understanding of MOR desensitization that leads to the development of tolerance and dependence.

20 December 2011 in British Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
FKFelicia Klinger
Felicia Klinger
PGPetra Geier
Petra Geier
MDMario M. Dorostkar
Mario M. Dorostkar
GCGiri K Chandaka
Giri K Chandaka
AYArsalan Yousuf
Arsalan Yousuf
Stefan BoehmStefan Boehm
Stefan Boehm
BACKGROUND AND PURPOSE: Flupirtine is a non‐opioid analgesic that has been in clinical use for more than 20 years. It is characterized as a selective neuronal potassium channel opener (SNEPCO). Nevertheless, its mechanisms of action remain controversial and are the purpose of this study.EXPERIMENTAL APPROACH: Effects of flupirtine on native and recombinant voltage‐ and ligand‐gated ion channels were explored in patch‐clamp experiments using the following experimental systems: recombinant KIR3 and KV7 channels and α3β4 nicotinic acetylcholine receptors expressed in tsA 201 cells; native voltage‐gated Na+, Ca2+, inward rectifier K+, KV7 K+, and TRPV1 channels, as well as GABAA, glycine, and ionotropic glutamate receptors expressed in rat dorsal root ganglion, dorsal horn and hippocampal neurons.KEY RESULTS: Therapeutic flupirtine concentrations (≤10 µM) did not affect voltage‐gated Na+ or Ca2+ channels, inward rectifier K+ channels, nicotinic acetylcholine receptors, glycine or ionotropic glutamate receptors. Flupirtine shifted the gating of KV7 K+ channels to more negative potentials and the gating of GABAA receptors to lower GABA concentrations. These latter effects were more pronounced in dorsal root ganglion and dorsal horn neurons than in hippocampal neurons. In dorsal root ganglion and dorsal horn neurons, the facilitatory effect of therapeutic flupirtine concentrations on KV7 channels and GABAA receptors was comparable, whereas in hippocampal neurons the effects on KV7 channels were more pronounced.CONCLUSIONS AND IMPLICATIONS: These results indicate that flupirtine exerts its analgesic action by acting on both GABAA receptors and KV7 channels.

1 November 2016 in Neuropharmacology
Verified
Journal Article
Open access
ISIsabella Salzer
Isabella Salzer
EGEnkhbileg Gantumur
Enkhbileg Gantumur
AYArsalan Yousuf
Arsalan Yousuf
Stefan BoehmStefan Boehm
Stefan Boehm
Serotonin (5HT) is a constituent of the so-called "inflammatory soup" that sensitizes nociceptors during inflammation. Nevertheless, receptors and signaling mechanisms that mediate an excitation of dorsal root ganglion (DRG) neurons by 5HT remained controversial. Therefore, capsaicin-sensitive nociceptive neurons dissociated from rat DRGs were used to investigate effects of 5HT on membrane excitability and currents through ligand- as well as voltage-gated ion channels. In 58% of the neurons tested, 5HT increased action potential firing, an effect that was abolished by the 5HT2 receptor antagonist ritanserin, but not by the 5HT3 antagonist tropisetron. Unlike other algogenic mediators, such as PGE2 and bradykinin, 5HT did not affect currents through TTX-resistant Na(+) channels or Kv7 K(+) channels. In all neurons investigated, 5HT potentiated capsaicin-evoked currents through TRPV1 channels, an effect that was attenuated by antagonists at 5HT2A (4 F 4 PP), 5HT2B (SB 204741), as well as 5HT2C (RS 102221) receptors. 5HT triggered slowly arising inward Cl(-) currents in 53% of the neurons. This effect was antagonized by the 5HT2C receptor blocker only, and the current was prevented by an inhibitor of Ca(2+)-activated chloride channels (CaCC). The 5HT-induced increase in action potential firing was also abolished by this CaCC blocker and by the TRPV1 inhibitor capsazepine. Amongst the subtype selective 5HT2 antagonists, only RS 102221 (5HT2C-selectively) counteracted the rise in action potential firing elicited by 5HT. These results show that 5HT excites DRG neurons mainly via 5HT2C receptors which concomitantly mediate a sensitization of TRPV1 channels and an opening of CaCCs.

1 August 2011 in Pain
Verified
Journal Article
Open access
AYArsalan Yousuf
Arsalan Yousuf
FKFelicia Klinger
Felicia Klinger
KSKlaus Schicker
Klaus Schicker
Stefan BoehmStefan Boehm
Stefan Boehm
N, but it remained enigmatic which G protein-coupled nucleotide (P2Y) receptors and associated signaling cascades are involved. To resolve this issue, nucleotides were applied to dorsal root ganglion neurons under current- and voltage-clamp. Adenosine triphosphate (ATP), adenosine diphosphate (ADP), and uridine triphosphate (UTP), but not uridine diphosphate (UDP), depolarized the neurons and enhanced action potential firing in response to current injections. The P2Y2 receptor preferring agonist 2-thio-UTP was equipotent to UTP in eliciting these effects. The selective P2Y1 receptor antagonist MRS2179 largely attenuated the excitatory effects of ADP, but left those of 2-thio-UTP unaltered. Thus, the excitatory effects of the nucleotides were mediated by 2 different P2Y receptors, P2Y1 and P2Y2. Activation of each of these 2 receptors by either ADP or 2-thio-UTP inhibited currents through KV7 channels, on one hand, and facilitated currents through TRPV1 channels, on the other hand. Both effects were abolished by inhibitors of phospholipase C or Ca2+-ATPase and by chelation of intracellular Ca2+. The facilitation of TRPV1, but not the inhibition KV7 channels, was prevented by a protein kinase C inhibitor. Simultaneous blockage of KV7 channels and of TRPV1 channels prevented nucleotide-induced membrane depolarization and action potential firing. Thus, P2Y1 and P2Y2 receptors mediate an excitation of dorsal root ganglion neurons by nucleotides through the inhibition of KV7 channels and the facilitation of TRPV1 channels via a common bifurcated signaling pathway relying on an increase in intracellular Ca2+ and an activation of protein kinase C, respectively....

1 October 2015 in Molecular Pharmacology
Verified
Journal Article
Closed access
PDF file
AYArsalan Yousuf
Arsalan Yousuf
EMElke Miess
Elke Miess
SSSetareh Sianati
Setareh Sianati
YDYan-Ping Du
Yan-Ping Du
SSStefan Schulz
Stefan Schulz
MCMacdonald Christie
Macdonald Christie
Phosphorylation of residues in the C-terminal tail of the µ-opioid receptor (MOPr) is thought to be a key step in desensitization and internalization. Phosphorylation of C-terminal S/T residues is required for internalization (Just et al., 2013), but its role in desensitization is unknown. This study examined the influence of C-terminal phosphorylation sites on rapid desensitization of MOPr. Wild-type MOPr, a 3S/T-A mutant (S363A, T370A, S375A) that maintains internalization, 6S/T-A (S363A, T370A, S375A, T376A, T379A, T383A) and 11S/T-A (all C-terminal S/T residues mutated) mutants not internalized by MOPr agonists were stably expressed in AtT20 cells. Perforated patch-clamp recordings of MOPr-mediated activation of G-protein–activated inwardly rectifying potassium channel (Kir3.X) (GIRK) conductance by submaximal concentrations of Met5-enkephalin (ME) and somatostatin (SST; coupling to native SST receptor [SSTR]) were used to examine desensitization induced by exposure to ME and morphine for 5 minutes at 37°C. The rates of ME- and morphine-induced desensitization did not correlate with phosphorylation using phosphorylation site-specific antibodies. ME-induced MOPr desensitization and resensitization did not differ from wild-type for 3S/T-A and 6S/T-A but was abolished in 11S/T-A. Morphine-induced desensitization was unaffected in all three mutants, as was heterologous desensitization of SSTR. Morphine-induced desensitization (but not ME) was reduced by protein kinase C inhibition in wild-type MOPr and abolished in the 11S/T-A mutant, as was heterologous desensitization. These findings establish that MOPr desensitization can occur independently of S/T phosphorylation and internalization; however, C-terminal phosphorylation is necessary for some forms of desensitization because mutation of all C-terminal sites (11S/T-A) abolishes desensitization induced by ME.

4 February 2019 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
SMShannon N. Mostyn
Shannon N. Mostyn
TRTristan Rawling
Tristan Rawling
SMSarasa Mohammadi
Sarasa Mohammadi
SSSusan Shimmon
Susan Shimmon
ZFZachary J. Frangos
Zachary J. Frangos
Robert VandenbergRobert Vandenberg
Robert Vandenberg